Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)

on behalf of the COMPACT Investigators

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following the publication of the original article [1] the authors informed us of an error in the second paragraph under ‘Study population’ of the ‘Results’ section.

Original languageEnglish (US)
Article number329
JournalOrphanet journal of rare diseases
Volume16
Issue number1
DOIs
StatePublished - Dec 2021
Externally publishedYes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)'. Together they form a unique fingerprint.

Cite this